Medicenna Therapeutics Corp.
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Medicenna Therapeutics Corp. generated cash of -$12,657,000, which is more than the previous year. Cash used in financing activities reached the amount of $24,760,000 last year. Net change in cash is therefore $13,061,000.
Cash Flow
| 2014 | -619 | 0 | 259 |
|---|---|---|---|
| 2015 | -880 | -2 | 1.00K |
| 2016 | -2.57M | 0 | 7.85M |
| 2017 | -7.30M | 603.14K | 15.38M |
| 2018 | -10.12M | -140.02K | 469.39K |
| 2019 | -8.03M | -354.45K | 6.82M |
| 2020 | -8.95M | -15M | 44.28M |
| 2021 | -15.31M | 5.01M | 18.25M |
| 2022 | -23.58M | 10.05M | 3.87M |
| 2023 | -12.65M | 0 | 24.76M |
MDNA Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 20.53M | 30.37M | 22.69M | 2.37M | 3.93M | 14.03M | 5.33M | 125.56K | 3 | 363 |
Operating activities | ||||||||||
Net income | -10.04M | -22.57M | -17.28M | -8.27M | -4.70M | -7.46M | -7.63M | -1.33M | -833 | -765 |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 4K | 38K | 40K | 7.89K | 6.81K | 9.70K | 6.48K | 1.43K | 0 | 0 |
Stock-based compensation expense | 1.37M | 1.41M | 1.00M | 1.12M | 998.61K | 1.61M | 140.18K | 0 | 0 | 0 |
| Deferred income tax benefit | 1.37M | 1.41M | 1.00M | 1.12M | 998.61K | 1.61M | 140.18K | 0 | 0 | 0 |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 1.23K | -392 | -1.61K | 139 | 56 | 0 | 0 | 0 | -15 | -13 |
Inventories | 0 | 392 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accounts payable | 0 | -1.45M | 0 | 0 | 0 | 451.87K | 782.14K | 313.67K | 0 | 0 |
Cash generated by operating activities | -12.65M | -23.58M | -15.31M | -8.95M | -8.03M | -10.12M | -7.30M | -2.57M | -880 | -619 |
Investing activities | ||||||||||
Purchases Of Investments | 0 | -10M | -10M | -15M | 0 | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | 0 | 0 | 0 | 0 | 0 | 0 | -5.38K | 0 | -2 | 0 |
Acquisitions Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | 0 | 10.05M | 5.01M | -15M | -354.45K | -140.02K | 603.14K | 0 | -2 | 0 |
Financing activities | ||||||||||
Common Stock Issued | 24.76M | 3.50M | 11.41M | 38.37M | 3.57M | 0 | 9.23M | 3.32M | 0 | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -40 | 0 | 0 |
Repayments of term debt | 0 | 0 | -39K | -3.39K | 0 | 0 | 0 | 0 | 0 | 0 |
Cash used in financing activities | 24.76M | 3.87M | 18.25M | 44.28M | 6.82M | 469.39K | 15.38M | 7.85M | 1.00K | 259 |
Net Change In Cash | 13.06M | -9.84M | 7.67M | 20.32M | -1.56M | -10.09M | 8.69M | 5.21M | 121 | -359 |
Cash at end of period | 33.59M | 20.53M | 30.37M | 22.69M | 2.37M | 3.93M | 14.03M | 5.33M | 125 | 3 |
| Data source | Data source |